University of California at Los Angeles SC — Los Angeles, California

University of California at Los Angeles SC is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of California at Los Angeles SC has participated in 1 clinical trials.

Therapeutic areas: Tuberous Sclerosis Complex-associated Refractory Seizures.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California at Los Angeles SC?

University of California at Los Angeles SC has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California at Los Angeles SC conducted?

University of California at Los Angeles SC has 1 clinical trials on record. Their work covers Tuberous Sclerosis Complex-associated Refractory Seizures.

Is University of California at Los Angeles SC accredited by Crixeo Health?

University of California at Los Angeles SC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California at Los Angeles SC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.